FIA
BCYC

FNY Investment Advisers’s Bicycle Therapeutics BCYC Stock Holding History

FNY Investment Advisers’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-157
Closed -$1K – 784
2025
Q4 		$1K Buy
157
+17
+12% +$125 ﹤0.01% 822
2025
Q3 		$1K Buy
+140
New +$1.06K ﹤0.01% 1111

Other funds holding BCYC

PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FNY Investment Advisers's BCYC Position: Q2 2026 in Review

FNY Investment Advisers increased its Bicycle Therapeutics (BCYC) stake by 247% in Q2 2026, buying an estimated $85.7K and bringing the position to 26,250 shares worth $111K. The position accounts for 0.04% of the portfolio, ranked #314.

FNY Investment Advisers first reported a position in BCYC in Q3 2025 and has held it in 4 quarters since. 32 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • FNY Investment Advisers held 26,250 shares of Bicycle Therapeutics worth $111K as of Q2 2026.
  • FNY Investment Advisers bought 18,693 Bicycle Therapeutics shares in Q2 2026, an estimated $85.7K.
  • Bicycle Therapeutics made up 0.04% of FNY Investment Advisers's portfolio in Q2 2026, its #314 holding.
  • FNY Investment Advisers first reported a position in Bicycle Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 32 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.